Top

Published in:

Open Access 01-06-2017 | Commentary

Why We should Assess Patients’ Expectations in Clinical Trials

Authors: Elisa Frisaldi, Aziz Shaibani, Fabrizio Benedetti

Published in: Pain and Therapy | Issue 1/2017

Abstract

Most of the analgesic clinical trials have failed to succeed over the past years because of the occurrence of large placebo responses. Patients’ expectations about the therapeutic benefit represent a major determinant of the placebo response. Therefore, assessing patients’ expectations should become the rule in any clinical trial. This would allow us to better interpret therapeutic outcomes when comparing placebo and verum groups.

Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects. Lancet Neurol. 2016;15:736–47.CrossRefPubMed

Shaibani A, Frisaldi E, Benedetti F. Placebo response in pain, fatigue, and performance: possible implications for neuromuscular disorders. Muscle Nerve. 2017. doi:10.1002/mus.25635.

Bartfai T, Lees GV. Pharma TARP: a troubled asset relief program for novel, abandoned projects in the pharmaceutical industry. Sci World J. 2011;11:454–7.CrossRef

Dolgin E. Fluctuating baseline pain implicated in failure of clinical trials. Nat Med. 2010;16:1053.

Katz J, Finnerup NB, Dworkin RH. Clinical trial outcome in neuropathic pain: relationship to study characteristics. Neurology. 2008;70:263–72.CrossRefPubMed

Tuttle AH, et al. Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain. 2015;156:2616–26.CrossRefPubMed

Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002;287:1840–7.CrossRefPubMed

Dworkin RH, Katz J, Gitlin MJ. Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain. Neurology. 2005;65:S7–19.CrossRefPubMed

Younger J, et al. Development of the Stanford Expectations of Treatment Scale (SETS): a tool for measuring patient outcome expectancy in clinical trials. Clin Trials. 2012;9:767–76.CrossRefPubMed

10.

Sneed JR, et al. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry. 2008;16:65–73.CrossRefPubMed

11.

Rutherford BR, Sneed JR, Roose SP. Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom. 2009;78:172–81.CrossRefPubMedPubMedCentral

12.

Rutherford BR, et al. Patient expectancy as a mediator of placebo effects in antidepressant clinical trials. Am J Psychiatry. 2017;174:135–42.CrossRefPubMed

13.

Bausell RB, et al. Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants’ perceived assignments in two placebo-controlled trials. Eval Health Prof. 2005;28:9–26.CrossRefPubMed

14.

Linde K, et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain. 2007;128:264–71.CrossRefPubMed

15.

Benedetti F, Durando J, Vighetti S. Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway. Pain. 2014;155:921–8.CrossRefPubMed

16.

Rief W, et al. Preoperative optimization of patient expectations improves long-term outcome in heart surgery patients: results of the randomized controlled PSY-HEART trial. BMC Med. 2017;10(15):4.CrossRef

17.

Daniels AM, Sallie R. Headache, lumbar puncture, and expectation. Lancet. 1981;1:1003.CrossRefPubMed

18.

Amanzio M, et al. A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain. 2009;146:261–9.CrossRefPubMed

19.

Giustini D. Social media and clinical trials recruitment: potential benefits and challenges. J Can Health Libr Assoc. 2012;33:140–5.CrossRef

20.

Allison M. Can Web 2.0 reboot clinical trials? Nat Biotech. 2009;27(895):902.

21.

Coons S. Communication through social media: its potential and pitfalls. Res Prac. 2012;13(44):50.

Title: Why We should Assess Patients’ Expectations in Clinical Trials
Authors: Elisa Frisaldi
Aziz Shaibani
Fabrizio Benedetti
Publication date: 01-06-2017
Publisher: Springer Healthcare
Published in: Pain and Therapy / Issue 1/2017
Print ISSN: 2193-8237
Electronic ISSN: 2193-651X
DOI: https://doi.org/10.1007/s40122-017-0071-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Why We should Assess Patients’ Expectations in Clinical Trials

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2017

Genetic Testing for Opioid Pain Management: A Primer

The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review

High Body Mass Index and Use of Fentanyl Iontophoretic Transdermal System in Postoperative Pain Management: Results of a Pooled Analysis of Six Phase 3/3B Trials

Valuing Individuals’ Preferences and Health Choices of Physical Exercise

Prevalence and Incidence Trends for Diagnosed Prescription Opioid Use Disorders in the United Kingdom

Frequency of Shoulder Corticosteroid Injections for Pain and Stiffness After Shoulder Surgery and Their Potential to Enhance Outcomes with Physiotherapy: A Retrospective Study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page